153 related articles for article (PubMed ID: 4359674)
1. Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma.
Hsu MM; Chiou JF; McCabe BF
Ann Otol Rhinol Laryngol; 1974; 83(1):19-25. PubMed ID: 4359674
[No Abstract] [Full Text] [Related]
2. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.
Lynn T; Tu S; Hirayama T; Kawamura A
Jpn J Exp Med; 1973 Apr; 43(2):135-44. PubMed ID: 4352112
[No Abstract] [Full Text] [Related]
3. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
Henle W; Ho JH; Henle G; Chau JC; Kwan HC
Int J Cancer; 1977 Nov; 20(5):663-72. PubMed ID: 200569
[No Abstract] [Full Text] [Related]
4. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
Henle W; Henle G; Ho JH
IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
[No Abstract] [Full Text] [Related]
5. Serum glycoproteins and immunoglobulins in nasopharyngeal carcinoma: correlations with Epstein-Barr virus associated antibodies and clinical tumor stage.
Baskies AM; Chretien PB; Yang C; Wolf GT; Makuch RW; Tu S; Hsu M; Lynn T; Yang H; Weiss JF; Spiegel HE
Am J Surg; 1979 Oct; 138(4):478-88. PubMed ID: 225960
[No Abstract] [Full Text] [Related]
6. Relationship between the Epstein-Barr virus genome and nasopharyngeal carcinoma in Caucasian patients.
Andersson-Anvret M; Forsby N; Klein G; Henle W; Biörklund A
Int J Cancer; 1979 Jun; 23(6):762-7. PubMed ID: 223991
[TBL] [Abstract][Full Text] [Related]
7. Undifferentiated carcinoma of nasopharyngeal type of tonsil.
Klijanienko J; Micheau C; Azli N; Cvitkovic E; Eschwege F; Marandas P; Armand JP; Casiraghi O; Schwaab G; de Vathaire F
Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):731-4. PubMed ID: 2541744
[TBL] [Abstract][Full Text] [Related]
8. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
Lynn T; Tu S; Hirayama T; Kawamura A
Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111
[No Abstract] [Full Text] [Related]
9. [Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx].
Yomi J; Fouda A; Fossi A; Bejanga B
Bull Cancer Radiother; 1996; 83(3):168-9. PubMed ID: 8977568
[No Abstract] [Full Text] [Related]
10. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
Mazeron MC
Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated antibodies and serum biochemistry in nasopharyngeal carcinoma.
Lynn TC; Hsieh RP; Chuang CY; Huang SC; Hsieh T; Tu SM
Laryngoscope; 1984 Nov; 94(11 Pt 1):1485-8. PubMed ID: 6092804
[TBL] [Abstract][Full Text] [Related]
12. Further studies on antibodies to early antigens induced by Epstein-Barr virus in nasopharyngeal carcinoma patients.
Ida S; Hinuma Y; Chu CT; Chiou JF; Lai JG
Gan; 1973 Dec; 64(6):545-53. PubMed ID: 4360581
[No Abstract] [Full Text] [Related]
13. Prognosis of nasopharyngeal carcinoma by Epstein-Barr virus antibody titer.
Lynn T; Hsu M; Hsieh T; Tu S
Arch Otolaryngol; 1977 Mar; 103(3):128-32. PubMed ID: 189741
[TBL] [Abstract][Full Text] [Related]
14. [Detection of antibodies against Epstein's and Barr's virus in patients with carcinoma of the nasopharynx in the CSSR (author's transl)].
Síbl O; Vonka V; Vlcková I; Závadová H
Cas Lek Cesk; 1974 Oct; 113(42):1284-7. PubMed ID: 4370878
[No Abstract] [Full Text] [Related]
15. Epstein-Barr Virus antibodies in patients with carcinoma of the nasopharynx and carcinoma of other sites in the head and neck.
Sako K; Minowada J; Marchetta FC
Am J Surg; 1975 Oct; 130(4):437-9. PubMed ID: 170838
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus induces viral nuclear antigen in nasopharyngeal epithelial cells.
Desgranges C; de-Thé G
Lancet; 1977 Dec; 2(8051):1286-7. PubMed ID: 73981
[No Abstract] [Full Text] [Related]
17. [Experimental studies on viral etiology of Epstein-Barr (EBV) in nasopharyngeal carcinoma (NPC):establishment of EBV infection on human epithelial derived from nasopharyngeal tissue (author's transl)].
Takimoto T
Nihon Jibiinkoka Gakkai Kaiho; 1979 Feb; 82(2):119-35. PubMed ID: 220401
[No Abstract] [Full Text] [Related]
18. The etiology of nasopharyngeal carcinoma.
de Thé G
Pathobiol Annu; 1972; 2():235-54. PubMed ID: 4589746
[No Abstract] [Full Text] [Related]
19. Squamous carcinoma of the nasopharynx.
Moloy PJ; Chung YT; Krivitsky PB; Kim RC
West J Med; 1985 Jul; 143(1):66-9. PubMed ID: 2994305
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.
Huang DP; Ho JH; Henle W; Henle G
Int J Cancer; 1974 Nov; 14(5):580-8. PubMed ID: 4142471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
